Session Information
Regional Event: sw
Start Date: 11/19/2022 1:00 pm
End Date: 11/19/2022 2:40 pm
Location: Royal Ballroom III
Speakers in this session
-
Kyle Nevius
Kyle Nevius DC
Dr. Kyle Nevius has been in practice as a chiropractor since 1987. His original background started in pre-hospital emergency medicine. He was the Owner/Director/pilot of the Level I Critical Care Fixed Wing Air Ambulance Service for Southwest Florida for over 10 years. He was introduced to chiropractic, after suffering multiple injuries as a professional driver for Porsche motor-sports. He was actually referred by an emergency room physician, who became a lifelong friend. Subsequently, his chiropractic physician became very instrumental in his rehabilitation and career! As a chiropractor himself, he has been extremely involved in his community, sitting on boards/committees such as Special Olympics Florida, the Florida Worker’s Compensation Oversight Board, and the Occupational Physician Advisory Panel at Naples Community Hospital, where he continues to be a member of Health Partners (PHO). He served as the chairman of the board at the Collier county chapter of the American Red Cross directing disaster relief efforts through hurricane Andrew. During all that, he was also the only Naples DC to serve as the president for the FCA Board of Directors and was the team physician for Naples High School for 7 years!! He is the author of “Corporate Healthcare Florida” used by chiropractic and allopathic physicians for work related injuries. Dr. Nevius serves 12 large south west Florida employers with over 10,000 employees providing evaluation and treatment for workers compensation injuries. He is the prehospital rotary wing director for Sebring International Raceway. He is an expert medical advisor for the state of Florida and is a consultant to the Agency for Healthcare Administration.
Sessions...
Integration of Cannabidiol (CBD oil) for Chiropractic Physicians
Regional Event: sw
Start Date: 11/19/2022 1:00 pm
End Date: 11/19/2022 2:40 pm
Location: Royal Ballroom III
Session details
Course Description
In this session attendees will learn the history, development and current utilization of industrial hemp products/CBD oil and their uses in healthcare. This course will discuss the healthcare revolution as it occurred in 2012 and subsequent global media explosion that started research in 52 countries, it will include treatment categories by the Mayo Clinic and database management by John’s Hopkins University. Information regarding guidelines for diagnoses, drug interaction and loading dose approach will be briefly discussed. legal considerations will be reviewed from a state and federal level.
Learning Objectives
• Learn the difference between controlled and non-controlled CBD products as approved for use by the FDA within the United States and Florida
• Identify discuss and differentiate between medicinal marijuana products and non-controlled CBD oil as it relates to prescription and nonprescription treatment
• Learn about the history of hemp-based CBD oil in the United States and its utilization in healthcare as well as other non-healthcare related industries
• Review and understand the data as it relates to CB one and CB two receptors and how that will play an integral role with their patients’ healthcare management
• Learn about the involvement of Johns Hopkins University outpatient treatment program and data acquisition as well as treatment categories currently being developed by the Mayo Clinic as it relates to CBD oil intervention
Course Description
In this session attendees will learn the history, development and current utilization of industrial hemp products/CBD oil and their uses in healthcare. This course will discuss the healthcare revolution as it occurred in 2012 and subsequent global media explosion that started research in 52 countries, it will include treatment categories by the Mayo Clinic and database management by John’s Hopkins University. Information regarding guidelines for diagnoses, drug interaction and loading dose approach will be briefly discussed. legal considerations will be reviewed from a state and federal level.
Learning Objectives
• Learn the difference between controlled and non-controlled CBD products as approved for use by the FDA within the United States and Florida
• Identify discuss and differentiate between medicinal marijuana products and non-controlled CBD oil as it relates to prescription and nonprescription treatment
• Learn about the history of hemp-based CBD oil in the United States and its utilization in healthcare as well as other non-healthcare related industries
• Review and understand the data as it relates to CB one and CB two receptors and how that will play an integral role with their patients’ healthcare management
• Learn about the involvement of Johns Hopkins University outpatient treatment program and data acquisition as well as treatment categories currently being developed by the Mayo Clinic as it relates to CBD oil intervention